MDL12330A
Based on 6 publication(s) in Google Scholar
MDL12330A (RMI12330A) is an adenylyl cyclases inhibitor. MDL12330A can inhibit KV channels, increases insulin secretion and Ca2+ levels. MDL12330A accentuates contractions in uterine rings and inhibits cardiac functions. MDL12330A can be used for the research of endocrinology, metabolic and cardiovascular disease .
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.82%
- CAS No.: 40297-09-4
- Formule: C23H37ClN2
- Masse moléculaire:377.01
-
Stockage:
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
-
GPCR/G Protein Compound Library
HY-L006
-
Membrane Transporter/Ion Channel Compound Library
HY-L011
-
Macrocyclic Compound Library
HY-L041
-
Anti-Cardiovascular Disease Compound Library
HY-L046
-
Anti-Alzheimer's Disease Compound Library
HY-L069
-
Neurodegenerative Disease-related Compound Library
HY-L086
-
Potassium Channel Compound Library
HY-L119
-
Membrane Protein-targeted Compound Library
HY-L149
-
Membrane Receptor-targeted Compound Library
HY-L150
-
Ion Channel Compound Library
HY-L166
-
Multi-Target Compound Library
HY-L176
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Bioactive Compound Library
HY-L001
-
High-Throughput Bioactive Compound Library
HY-L205
-
Lactylation Compound Library
HY-L249
Publications Citing Use of MedChemExpress (MCE) MDL12330A
More
Activité biologique
MDL12330A (10 μM) increases insulin secretion and produces prolonged APDs in pancreatic beta cells[1].
MDL-12,330A (10 μM) inhibits KV channels and increases Ca2+ levels in pancreatic beta cells[1].
MDL12330A (10 μM, 30 min) accentuates contractions in uterine rings from rats at mid gestation but not at term gestation or at term gestation in labor[2].
MDL12330A inhibits all cardiac functions in isolated active hearts of guinea pigs with an IC50 of 1.1 μM, including contractile force, dP/dt, dF/dt, pressure development, and activity performance[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 40297-09-4
-
Appearance Solid
-
Masse moléculaire 377.01
-
Formule C23H37ClN2
-
Color White to off-white
-
SMILES
[H]Cl.C1(/N[C@@H]2[C@H](C3=CC=CC=C3)CCC2)=N/CCCCCCCCCCC1
-
Synonyms
RMI12330A
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Publications (6)
-
Journal Impact Factor
-
Most Recent
-
Cell Host Microbe
Enterococcus faecalis-derived lactic acid suppresses macrophage activation to facilitate persistent and polymicrobial wound infections. [Abstract]2026 Feb 11;34(2):245-262.e8. PMID: 41605216 -
-
Andrology
Cellular mechanism underlying leptin-induced anion secretion of rat epididymal epithelial cells. [Abstract]2024 May 22. PMID: 38778669 -
Cytotechnology
Exploring the laxative effects of emodin on constipation through chloride channel activation. [Abstract]2026 Jun;78(3):104. PMID: 42083655 -
-
Solvant et solubilité
DMSO : 20 mg/mL (53.05 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (275 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Okawa T, et al. Role of nucleotide cyclases in the inhibition of pregnant rat uterine contractions by the openers of potassium channels. Am J Obstet Gynecol. 2000;182(4):913-918. [Content Brief]
[2]. Li X, et al. The adenylyl cyclase inhibitor MDL-12,330A potentiates insulin secretion via blockade of voltage-dependent K(+) channels in pancreatic beta cells. PLoS One. 2013;8(10):e77934. Published 2013 Oct 29. [Content Brief]
[3]. Grupp G, et al. Effects of RMI 12330A, a new inhibitor of adenylate cyclase on myocardial function and subcellular activity. Br J Pharmacol. 1980 Nov;70(3):429-42. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.6524 mL | 13.2622 mL | 26.5245 mL | 66.3112 mL |
| 5 mM | 0.5305 mL | 2.6524 mL | 5.3049 mL | 13.2622 mL | |
| 10 mM | 0.2652 mL | 1.3262 mL | 2.6524 mL | 6.6311 mL | |
| 15 mM | 0.1768 mL | 0.8841 mL | 1.7683 mL | 4.4207 mL | |
| 20 mM | 0.1326 mL | 0.6631 mL | 1.3262 mL | 3.3156 mL | |
| 25 mM | 0.1061 mL | 0.5305 mL | 1.0610 mL | 2.6524 mL | |
| 30 mM | 0.0884 mL | 0.4421 mL | 0.8841 mL | 2.2104 mL | |
| 40 mM | 0.0663 mL | 0.3316 mL | 0.6631 mL | 1.6578 mL | |
| 50 mM | 0.0530 mL | 0.2652 mL | 0.5305 mL | 1.3262 mL |
MDL12330A Related Classifications
HY-103192 Related Classifications
Powered by Bioz
- MDL12330A
- 40297-09-4
- RMI12330A
- Adenylate Cyclase
- Potassium Channel
- adenylate cyclase
- cyclic adenosine monophosphate
- mid-gestation uterine rings
- insulin secretion
- voltage-dependent Ca2+ channels
- potassium channel
- voltage-dependent K+ (KV) channels
- pancreatic beta cells
- uterine tissue
- uterine contractility
- Inhibitor
- inhibitor
- inhibit